Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial

TEMPO 4:4 Trial Investigators

Research output: Contribution to journalArticlepeer-review

22 Scopus citations
Original languageEnglish (US)
Pages (from-to)1262
Number of pages1
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Volume32
Issue number7
DOIs
StatePublished - Jul 1 2017

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this